Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nanotech risk survey

This article was originally published in The Tan Sheet

Executive Summary

The German Federal Institute for Risk Assessment (BfR) is conducting an expert survey on the risk of nanotechnology, the agency announces Aug. 22. The expert survey will focus on nanotechnology in foods, cosmetics and consumer goods. About 100 experts will participate in the multi-phase qualitative forecasting survey discussing current and future applications of nanotechnology and the opportunities and risks for consumers, the agency says. "The objective is to identify already used or potentially usable nanomaterials, assign them to concrete applications and then draw conclusions on consumer exposure," the institute states. Toward the end of the year, BfR will stage a "Consumer Conference on Perception of Nanotechnology." A final report on the conference will be made available to industry, "main stakeholders in the political circles," public agencies, scientists and non-governmental organizations, according to the release. "Both projects will help to identify scientifically determined and emotionally perceived risks early on and to carry them over to the communication process," BfR President Andreas Hensel states...

You may also be interested in...

Nichi-Iko Resumes Production After Suspension

Nichi Iko says it has restarted production at its Namerikawa manufacturing plant after the Japanese firm was forced to suspend operations due to alleged GMP violations.

France To Replace AstraZeneca Booster With mRNA Jab In Under-55s

The French authorities believe that the “heterologous prime-boost” approach is justified in the case of people aged under 55 years who are due to receive their second dose of the AZ COVID-19 vaccine.

European Medicines Data Standards Offer Business Opportunities For Life Science Firms

The newly published EU IDMP guide on implementing ISO data standards for the identification of medicinal products will keep regulatory affairs professionals busy with compliance work while also creating new data-driven opportunities for life sciences companies. Remco Munnik shares the inside track from his work with the EU focus group that created the guide.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts